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Abstract
Aberrant  centrosome  numbers  are  detected  in  virtually  all 
cancers increasing the risk for cell division errors and chromosomal instability. 
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Deregulation  of  the  centrosome  duplication  cycle  is  considered  as  the  major 
contributing  factor  for  abnormal  ampli cation  of  centrosomes.  p21fi Waf1 and  p27Kip1, 
general CDK inhibitors by inhibiting cyclin-dependent kinase 2 (CDK2)/cyclin E and 
cyclin A complexes, controlled the initiation and progress of centrosome duplication . 
We transfected p21 Waf1, p27 Kip1 or p21 Waf1- p27 Kip1 genes into MCF-7 cells by lipofection 
to explore the effect of the genes on centrosome duplication and proliferation of breast 
cancer cell. The result shows that the cell growth was obviously inhibited after being 
transfected, resulting in an accumulation of cells in G1 and the proportion of cells which 
contained abnormal centrosomes was obviously decreased. Comparing with p21 Waf1or 
p27  Kip1,  the  effects  of  p21Waf1-  p27  Kip1 genes  are  more  significative.  These  results 
suggest that p21Waf1 and p27Kip1 genes could inhibit the growth of human breast cancer 
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cells and reverse abnormal duplication of centrosomes. p21Waf1and p27Kip1 cooperate to 
regulate centrosome duplication and cell cycle progress, indicating p21  Waf1- p27 Kip1 
combined gene might be potential therapeutic agents of breast cancer which  reveals 
suppressed p21Waf1 and p27Kip1 expression.  
 
 Key words: Centrosome; Cell Proliferation; p21waf1 gene; p27kip1 gene; Breast neoplasms
Introduction
   The centrosome is the major microtubule organizing center during interphase and 
mitosis in most animal and human cells [1].  Each centrosome consists of a pair  of 
centrioles and a surrounding protein matrix referred to as pericentriolar materials [2]. 
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During interphase, centrosomes organize the cytoplasmic microtubule network, which 
is  involved  in  vesicle  transport,  proper  distribution  of  small  organelles,  and 
establishment of cellular shape and polarity. During mitosis, duplicated centrosomes 
direct  formation  of  bipolar  spindles,  which  is  critical  for  accurate  segregation  of 
chromosomes and cytokinesis [3]. The centrosome duplicates once every cell  cycle, 
which starts during the G1-S transition, coincident with the onset of DNA replication. 
Abrogation  of  regulatory  mechanisms  governing  centrosome  duplication  leads  to 
generation of amplified centrosomes (more than two centrosomes), which in turn leads 
to mitotic aberration (multipolar spindles) and unequal segregation of chromosomes[3]. 
Destabilization of chromosomes by centrosome amplification aids acquisition of further 
malignant phenotypes, hence promoting tumor progression. Recent studies have shown 
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that  centrosome  hyperampli cation  is  commonly  observed,  and  is  the  majorfi  
contributing factor for chromosome instability in human tumors [4–7].  Moreover, a 
significant reduction of p21Waf1 and p27Kip1 expression, which occurs at a high frequency 
in  human  cancer  [8-12],  strongly  correlates  with  the  occurrence  of  centrosome 
hyperampli cation.  p21fi Waf1 and  p27Kip1,  general  CDK  inhibitors, mainly  inhibits 
cyclin/CDK2 complexes,  thereby arresting  the  cell  cycle[13,14].  Some reports  have 
shown that the activation of CDK2/cyclinE (and cyclinA) is essential for the initiation 
of centrosome duplication[15]. It is not difficult to consider the role of p21Waf1 and 
p27Kip1 in centrosome homeostasis. In one of the first related studies, cells deficient of 
p21 and exposed to ionizing radiation were found to accumulate abnormal numbers of 
centrosomes following abortive mitoses[16]. Similar results were obtained in p27–/– 
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and p27+/– mouse embryonic fibroblasts and p27-silenced human cells [17]. Thus, both 
CDK inhibitors regulate centrosome duplicatin and cooperation of p21 and p27 might 
be important for accurate chromosome duplication.  Furthermore, inhibitory effects of 
CDK inhibitors, p21Waf1 and p27Kip1, on repeated centrosome reproduction were reported 
in frog embryos and Xenopus egg extracts[18-20]. But whether p21Waf1 and p27Kip1 can 
inhibite  the abnormal  duplication of centrosomes in  breast  cancer  cells  is  not  well 
known. 
   In this study,  we transfected p21 waf1, p27 kip1 and p21 waf1- p27 kip1 genes into MCF-7 
cells by lipofection to explore the role of p21Waf1 and p27Kip1 as a therapeutic target in 
breast cancer and the mechanism of interation between p21Waf1 and p27Kip1.
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Materials and Methods
 
Reagents and antibodies. 
pIRES-p21waf1 pIRES- p27kip1 and pIRES-p21waf1- p27kip1 were generous gifts from 
LIU Xiang-ping. A human breast carcinoma cell line MCF-7 was purchased form 
Chinese Academy of Science. p21Waf1 and p27Kip1 antibodies were purchased  form Santa 
Cruz Biotechnology (Santa Cruz, CA). Horseradish peroxidase (HRP)-conjugated anti-
mouse was obtained from Boster(Wuhan,China). The -tubulin antibody and a FITC 
conjugated secondary antibody were purchased form BD Pharmingen. All fine 
chemicals were purchased from Sigma. The ECL detection system was obtained from 
Amersham Biosciences (Piscataway, NJ). All cell culture products were purchased from 
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Jinuo(Hangzhou, China). Llipofectamine 2000 was purchased from Invitrogen (Grand 
Island, NY).
Cell line and transfection. 
The human breast carcinoma cell line MCF-7 was grown in Dulbecco’s modified 
Eagle’s medium (DMEM) containing 10% fetal bovine serum (FBS) at 37  in 5% CO2 
incubator. The recombinant plasmids pIRES-p21 Waf1, pIRES- p27 Kip1 and pIRES-p21 
Waf1
- p27 Kip1 were generously provided by Dr. Liu(center laboratory Qingdao, 
China). MCF-7 cells were transfected with these plasmids using lipofectamine. 
Western blot analysis. 
Cells were lysed in RIPA buffer [20 mM Tris–HCl, pH8.0, 1 mM EDTA, 1mM 
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EGTA, 150 mM NaCl, 0.1% (w/v)SDS, 1.0% (v/v) NP-40], which contained 
Completek-Mini protease inhibitors. The amount of proteins was determined using a 
Bradford protein assay kit (Bio-Rad, Hercules, CA). An aliquot of 50 g  proteins from 
a total lysate was electrophoresed on SDS-PAGE gel and then transferred to Immobilon-
P (Millipore, Bedford, MA). After blocking with 5% nonfat dry milk in Tris-buffered 
saline (TBS), the membrane was incubated with a primary antibody at an appropriate 
dilution overnight at 4  and then washed three times in TBST. The membrane was 
then incubated with a secondary antibody at a dilution of 1:5,000 at room temperature 
for 1h and again washed three times in TBST. The blots were visualized with ECL 
(Amersham).
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Flow cytometry. 
The cells were fixed in 70 % ethanol for 1 hour at 4 °C. The fixed cells were 
incubated with PBS with 300 µg/mL RNase A at room temperature and stained with 50 
µg/mL propidium iodide. Flow cytometric analysis was done with FACSC alibur and 
Cell Quest software (Becton Dickinson, San Jose, CA). 
Indirect immunofluorescence. 
Cells grown on slides were fixed with 4 % formalin for 20 min at 25 .  The cells 
were permeabilized with 0.2 % Triton X-100 for 30 min, followed by incubation with 
blocking solution (10 % normal goat serum in PBS) for 1h. Cells were then probed with 
primary antibody for 1h and antibody-antigen complexes were detected with FITC-
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conjugated goat secondary antibody by incubation for 1 h at 25 .  The samples were 
washed three times with PBS after each incubation, and then counterstained with 4', 6-
diamidino-2-phenylindole (DAPI). 
Statistical analysis. 
Differences between two groups were compared using the two-tailed unpaired 
Student's t test. P < 0.05 was considered statistically significant.
Results
 
 Arrest of cell cycle and restoration of the normal centrosome duplication cycle by high 
expression of re-introducted p21Waf1
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   Several reports have shown that breast cancer cells lacking p21Waf1 exhibit centrosome 
amplification after DNA damage. And after induced DNA damage, the level of p21Waf1 
is gradually increases and centrosome amplification is suppressed. We decided to test 
whether re-introduction of p21Waf1 gene into MCF-7 can induce cell cycle arrest or 
restore the normal centrosome duplication cycle. The MCF-7 cells were transfected 
with a pIRES-p21Waf1, generating a MCF-7- p21Waf1 cell line that constitutively expresses 
P21 protein. As a control, a pIRES vector was transfected into the MCF-7 cells (MCF-
7-pIRES . 
After transfected 48 hours, a statistical significant increased p21Waf1 expression was 
detected by immunoblot analysis (Fig 1). At the same time, cells were analysed by flow 
cytometry(Fig 2). MCF-7- p21Waf1 cells showed a different cell cycle phase distribution 
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from the control MCF-7-pIRES. MCF-7- p21Waf1 cell increased the number of cells in 
G1 phase P<0.01 and decreased the number of cells in S phase, indicating 
that p21Waf1 overexpression can inhibit cell cycle progression resulting in an 
accumulation of cells in G1. 
The centrosome in the MCF-7- p21Waf1 cell line was examined using antibody 
against - tubulin, a major component of centrosomes (Figure 3). As the control, MCF-
7-pIRES cells were also immunostained. MCF-7-pIRES cells showed an expected 
abnormal centrosome profile, 13% of the cells contained abnormally amplified 
centrosomes (n 3). In contrast, MCF-7- p21Waf1 cells showed a partial restoration of 
centrosome profile; an increase in the number of cells with one or two centrosomes and 
a decrease in the number of cells with n 3  centrosomes(4%),  demonstrating that re-
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introduction of physiological high level of p21Waf1 re-established the normal centrosome 
profile.
   These observations demonstrate that p21Waf1 is directly involved in the controlling the 
coordinated initiation of centrosome and DNA duplication. p21Waf1 overexpression can 
induce cell cycle attest and restoration of the normal centrosome duplication cycle in 
breast cancer.
Arrest of cell cycle progression and restoration of the normal centrosome 
duplication cycle by high expression of re-introduced p27Kip1
p27Kip1, as the related CDK inhibitor, also exhibited a significant reduction in most 
human aggressive tumors(16). We transfected pIRES-p27Kip1 into the MCF-7 cells to 
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explore effect of transfected p27Kip1 gene on the duplication of centrosomes and the 
proliferation of human breast carcinoma cells. 
After transfected 48 hours, a statistical significant increase p27Kip1 expression was 
detected by immunoblot analysis (Fig 1). At the same time, cells were analysed by flow 
cytometry(Fig 2) MCF-7- p27Kip1 cells showed a different cell cycle phase 
distribution from the control MCF-7-pIRES. MCF-7- p27Kip1 cell increased he number 
of cells in G1 phase P<0.01 and decreased the number of cells in S phase, 
indicating that p27Kip1 overexpression can inhibit cell cycle 
progression presumably during the G1/S transition period, resulting in an 
accumulation of cells in G1.  
The centrosome in the MCF-7- p27Kip1 cell line was examined using antibody against 
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- tubulin (Fig3). Comparing with the controlled MCF-7-pIRES cells, MCF-7-p27Kip1 
cells showed a partial restoration of centrosome profile; an increase in the number of 
cells with one or two centrosomes and a decrease in the number of cells with n 3  
centrosomes(6%), suggesting re-introduction of physiological high level of p27Kip1 re-
established the normal centrosome profile.
The effect of cooperation of p21Waf1 and p27Kip1 on the duplication of centrosome 
and the proliferation of human breast cancer cell
   The above results demonstrated that both p21Waf1 and p27Kip1 can inhibit cell cycle 
transition and restore centrosome duplication. As the related CDK inhibiters, the 
cooperation of both might be important for the progression of cell cycle and centrosome 
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duplication. Therefore we test whether p21Waf1- p27Kip1 combination get more effective 
inhibit effects.
The recombinant pIRES-p21Waf1- p27Kip1 was constructed and transfected into the 
MCF-7 to generate a MCF-7- p21Waf1- p27Kip1 cell line that constitutively expresses P21 
and P27 proteins. 
After transfected 48 hours, a similar significant increased P21 and P27 proteins 
expression were detected as the same as the expression in MCF-7- p21Waf1 cells and 
MCF-7- p27Kip1 cells(Fig 1). By flow cytometry, MCF-7- p21Waf1- p27Kip1 cells showed a 
different cell cycle phase distribution from the controls, MCF-7- p21Waf1 and MCF-7- 
p27Kip1. MCF-7- p21Waf1- p27Kip1 cells exhibited an increase in the number of cells in G1 
phase P<0.01 and a decrease in the number of cells in S phase (Fig 2), 
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indicating that p21Waf1 and p27Kip1 combination exhibited more evident inhibit effects on 
cell cycle progression than p21Waf1 or p27Kip1 single gene. 
   As anticipation, in contrast to the controls, MCF-7- p21Waf1- p27Kip1 cells showed a 
statistical increase in the number of cells with one or two centrosomes and a decrease in 
the number of cells with n 3  centrosomes(2%) (Fig 3), further demonstrating that 
p21Waf1-p27Kip1 combination is a more effective inhibitor than p21Waf1 or p27Kip1 single 
gene.
    Several studies have suggested that both p21Waf1 and p27Kip1, general inhibitors of 
cyclin-dependent kinases in G1 and S phase, can interact with many different cyclin-
CDK complexes. This interaction is mediated by a homologous domain. Our results 
indicated the association between p21Waf1 and p27Kip1 and suggested that the association 
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of p21Waf1 and p27Kip1 plays a crucial role to assure the accurate cell cycle transition and 
centrosome duplication. But the specific mechanism is still poorly understood.
    
Discussion
   Defect in the fidelity of chromosome segregation is a common characteristic of cancer 
cells and are likely to be important in the progression of a cancerous phenotype. Studies 
of cultured cells and tumor tissues have shown that tumorgenesis associated with 
suppressed p21Waf1 and p27Kip1 is primarily attributed to the deregulated centrosome 
duplication cycle and the consequential centrosome hyperampli cation. fi
   CDKs, a family of serine/threonine kinases, control the onset of the major cell 
cycle events such as DNA synthesis and mitosis, and also the accurate duplication of 
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centrosome. The activity of CDKs is in part regulated by association of different 
cyclins, which are temporally expressed at specific cell cycle stages. CDK inhibitors 
p21Waf1 and p27Kip1 interact with these complexes and thereby inhibit CDKs activity [19]. 
Labaer[21] and Nomura[22] found the differences between p21Waf1 and p27Kip1, when 
they study the function of CDK inhibitors. p21Waf1 inhibits the assembly of 
cyclinD/CDK4 complex which is the mainly active kinase complexes in mid-
earlier period of G1, and is considered as the major inhibitor in earlier G1. p27Kip1 firstly 
binds to cyclinD/CDK4 in earlier G1. After cyclinE/CDK4 complex formation, p27Kip1 is 
visible to bind to cyclinE/CDK4 complex in later G1 and inhibits the cell cycle 
transition. The accurate regulation of p21Waf1 and p27Kip1 is the major contributing factor 
for cell normal growth and development.
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p21Waf1, a general inhibitor of cyclin-dependent kinases in G1 and S phase, can bind 
to many different cyclin-CDK complexes, inhibit activity of nuclear cyclin-CDK 
complexes. Recent reports suggested that p21Waf1 controlled the initiation and progress 
of centrosome duplication by regulating cyclin/CDK2 activity[15]. One of the first 
related investigation was that cells lacking p21Waf1 were prone to centrosome 
amplification following a prolonged S phase arrest [23]. Additional support for a role of 
p21Waf1 in centrosome duplication came from studies that The human papillomavirus 
type 16 E7 (HPV-16 E7) oncoprotein, which inactivates p21Waf1 [24,25] was found to 
stimulate centrosome overduplication[26]. In keeping with these findings, depletion of 
p21Waf1 in human hematopoietic cells was found to cause abnormal centrosome numbers 
together with a deformed nuclear architecture and polyploidy[27]. In our studies, we 
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found the abnormal duplication of centrosome in MCF-7 breast cancer, following a 
suppressed expression of p21Waf1. This is consistent with previous research rusult that 
centrosome aberrations in primary invasive breast cancer are associated with nodal 
status and hormone receptor expression[28]. Furthermore, after transfected exogenous 
p21Waf1, MCF-7 breast cancer cells with p21Waf1 overexpression, exhibited the arrest of 
cell cycle progression and restoration of the normal centrosome duplication cycle. 
These results are consistent with our prior studies and supported by a report that p21Waf1 
overexpression can inhibit centrosome overduplication of cells treated with hydroxyurea 
for a long time[15,29]. 
p27Kip1, similar with p21Waf1, was initially identified as a negative regulator of G1 
progression in growth-arrested cells [30-32] and required to ensure the coordinated
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progression of centrosome duplication and cell cycle progress. Some reports have 
suggested that abnormal mitotic cells with amplified centrosomes were frequently 
observed in p27-silenced cells [17]. Furthermore, silencing of Skp2 by siRNA leads to 
P27 accumulation, reduction of CDK2 activity and suppression of centrosome 
amplification in lung cancer cells [33]. We observed that MCF-7 breast cancer cells 
transfected with p27Kip1 presented cell cycle inhibition and abnormal centrosome 
amplification suppression, suggesting that p27Kip1 could suppress cell cycle transition 
and restore centrosome amplification in breast cancer cells.
We show here that both p21Waf1 and p27Kip1 contribute to suppress CDK2 activity, 
arresting cell cycle progress and centrosome amplification. Either defection of p21Waf1 
or p27Kip1 can induce cell cycle disorder and centrosome amplification. Thus, there 
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remained a possibility that p21Waf1 and p27Kip1 cooperate to regulate cell cycle progress 
and centrosome duplication depending on the differences between p21Waf1 and p27Kip1 in 
molecular structure, control methods, pathway activity and mode of action. Our study 
found that p21Waf1- p27Kip1 combination had more significant inhibition of cell cycle 
progress and centrosome amplification than p21Waf1 or p27Kip1 single gene. These results 
lend support to the hypothesis that the cooperation of p21Waf1 and p27Kip1 play a synergia 
role in regulating the cell cycle progress and centrosome duplication. 
The tumorigenesis and progression of breast cancer refer to a variety of 
oncogenes, tumor suppressor genes forming a network-control. Therefore study of a 
single gene is difficult to see the whole picture, and that of multiple genes and their 
linkages is closer to the body the actual situation.Our findings suggest that p21Waf1 and 
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p27Kip1 overexpression can inhibit cell proliferation through G1 cell cycle arrest and 
restore centrosome duplication through centrioles separation supression in breast 
cancer. Possibly because of the differences in molecular structure, control methods, 
pathway activity and mode of action, p21Waf1 and p27Kip1 cooperate to inhibit cell 
proliferation and centrosome duplication. Then p21 Waf1- p27 Kip1 combination might have 
potential clinical significance as therapeutic agents of breast cancer with suppressed 
p21Waf1 and p27Kip1 expression. Multi-gene therapy may provide a new idea for breast 
cancer gene therapy, but the mechanism of the synergy between p21Waf1 and p27Kip1 
remains to be further explored.
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